Literature DB >> 24027656

Notch Signaling Pathway in Pancreatic Cancer Progression.

Jia Ma1, Jun Xia, Lucio Miele, Fazlul H Sarkar, Zhiwei Wang.   

Abstract

Entities:  

Keywords:  EMT; Microrna; Notch; Pancreatic cancer; Stem cell; Therapy

Year:  2013        PMID： 24027656      PMCID： PMC3767173     

Source DB:  PubMed          Journal:  Pancreat Disord Ther        ISSN： 2165-7092


× No keyword cloud information.
  43 in total

1.  Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer.

Authors:  Cenap Güngör; Hilke Zander; Katharina E Effenberger; Yogesh K Vashist; Tatyana Kalinina; Jakob R Izbicki; Emre Yekebas; Maximilian Bockhorn
Journal:  Cancer Res       Date:  2011-06-01       Impact factor: 12.701

2.  The Notch signaling pathway is related to neurovascular progression of pancreatic cancer.

Authors:  Peter Büchler; Amiq Gazdhar; Mario Schubert; Nathalia Giese; Howard A Reber; Oscar J Hines; Thomas Giese; Güralp O Ceyhan; Michael Müller; Markus W Büchler; Helmut Friess
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

Review 3.  Notch signaling.

Authors:  Lucio Miele
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

Review 4.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

5.  Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells.

Authors:  Jun Xia; Qiaoling Duan; Aamir Ahmad; Bin Bao; Sanjeev Banerjee; Ying Shi; Jia Ma; Jian Geng; Zhiwen Chen; K M Wahidur Rahman; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

Review 6.  Cancer stem cells: an evolving concept.

Authors:  Long V Nguyen; Robert Vanner; Peter Dirks; Connie J Eaves
Journal:  Nat Rev Cancer       Date:  2012-01-12       Impact factor: 60.716

Review 7.  Targeting Notch signaling pathway to overcome drug resistance for cancer therapy.

Authors:  Zhiwei Wang; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-06-22

8.  Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer.

Authors:  Muxing Kang; Biao Jiang; Bin Xu; Wenjie Lu; Qingqu Guo; Qiuping Xie; Bo Zhang; Xin Dong; Daniel Chen; Yulian Wu
Journal:  Cancer Lett       Date:  2012-11-27       Impact factor: 8.679

Review 9.  Targeting Notch signaling in pancreatic cancer patients--rationale for new therapy.

Authors:  P Mysliwiec; M J Boucher
Journal:  Adv Med Sci       Date:  2009       Impact factor: 3.287

10.  Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells.

Authors:  Ayano Kabashima-Niibe; Hajime Higuchi; Hiromasa Takaishi; Yohei Masugi; Yumi Matsuzaki; Yo Mabuchi; Shinsuke Funakoshi; Masayuki Adachi; Yasuo Hamamoto; Shigeyuki Kawachi; Koichi Aiura; Yuko Kitagawa; Michiie Sakamoto; Toshifumi Hibi
Journal:  Cancer Sci       Date:  2013-01-11       Impact factor: 6.716
View more
  13 in total

Review 1.  Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.

Authors:  Cristiana Pistol Tanase; Ana Iulia Neagu; Laura Georgiana Necula; Cristina Mambet; Ana-Maria Enciu; Bogdan Calenic; Maria Linda Cruceru; Radu Albulescu
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

3.  HES1 as an independent prognostic marker in esophageal squamous cell carcinoma.

Authors:  Shaghayegh Taleb; Mohammad Reza Abbaszadegan; Meysam Moghbeli; Nasim Hayati Roudbari; Mohammad Mahdi Forghanifard
Journal:  J Gastrointest Cancer       Date:  2014-12

4.  Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.

Authors:  Selvi Kunnimalaiyaan; Jose Trevino; Susan Tsai; T Clark Gamblin; Muthusamy Kunnimalaiyaan
Journal:  Mol Cancer Ther       Date:  2015-04-17       Impact factor: 6.261

5.  Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.

Authors:  Yi-Liang Bi; Min Min; Wei Shen; Yan Liu
Journal:  Tumour Biol       Date:  2016-09-27

6.  Antitumor effect of water decoctions of taxus cuspidate on pancreatic cancer.

Authors:  Chao Qu; Zhen Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-25       Impact factor: 2.629

7.  MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.

Authors:  Tommaso Mazza; Massimiliano Copetti; Daniele Capocefalo; Caterina Fusilli; Tommaso Biagini; Massimo Carella; Antonio De Bonis; Nicola Mastrodonato; Ada Piepoli; Valerio Pazienza; Evaristo Maiello; Fabio Francesco di Mola; Pierluigi di Sebastiano; Angelo Andriulli; Francesca Tavano
Journal:  Oncotarget       Date:  2017-10-31

Review 8.  Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.

Authors:  Mohammad Aslam Aslam Khan; Shafquat Azim; Haseeb Zubair; Arun Bhardwaj; Girijesh Kumar Patel; Moh'd Khushman; Seema Singh; Ajay Pratap Singh
Journal:  Int J Mol Sci       Date:  2017-04-06       Impact factor: 5.923

9.  Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.

Authors:  Sivapriya Ponnurangam; Prasad R Dandawate; Animesh Dhar; Ossama W Tawfik; Rajashri R Parab; Prabhu Dutt Mishra; Prafull Ranadive; Rajiv Sharma; Girish Mahajan; Shahid Umar; Scott J Weir; Aravind Sugumar; Roy A Jensen; Subhash B Padhye; Arun Balakrishnan; Shrikant Anant; Dharmalingam Subramaniam
Journal:  Oncotarget       Date:  2016-01-19

10.  Effect of midkine on gemcitabine resistance in biliary tract cancer.

Authors:  Yongliang Lu; Bing Yan; Huihui Guo; Li Qiu; Xinrong Sun; Xiang Wang; Qian Shi; Ying Bao
Journal:  Int J Mol Med       Date:  2018-01-18       Impact factor: 4.101
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.